2m 2m 2m 2m 2m 2m 2m
FORTRESS BIOTCH (FBIO)
NASDAQ
$2.65-$0.48 (-15.50%)
Price as of Aug 03, 2026 11:32 AM EDT- $104.0MMarket Cap
- 72.93%1-Year Change
- BiotechnologyIndustry
FORTRESS BIOTCH (FBIO)
$2.65-$0.48 (-15.50%)
FBIO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.13 | ||
Change | -$0.16 (-4.86%) | ||
Open | $3.28 | ||
High | $3.28 | ||
Low | $3.08 | ||
Previous Close | $3.29 | ||
Volume | 642,775 | ||
30-Day Average Volume | 561,333 | ||
1-Week Change | -6.29% | ||
1-Month Change | 2.29% | ||
1-Year Change | 72.93% | ||
3-Year Change | -63.39% | ||
5-Year Change | -93.29% | ||
Fundamentals | |||
Shares Outstanding | 33.2M | ||
Total Assets | $356.9M | ||
Market Cap | $104.0M | ||
Enterprise Value | -$112.5M | ||
Period: QTR TTM FY | |||
Revenue | $16.0M | ||
Net Income | $110.4M | ||
Free Cash Flow | $203.9M | ||
EBIT | $117.8M | ||
EBITDA | $119.0M | ||
Net Working Capital | $192.1M | ||
EPS | $2.82 | ||
Enterprise Value/EBITDA | -1 | ||
Enterprise Value/Revenue | -7 | ||
P/B | 1 | ||
P/E | 1 | ||
PEG | 0 | ||
Price/Free Cash Flow | 1 | ||
Price/Operating Cash Flow | 1 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 15 | ||
Last Split Date | 10/10/2023 | ||
Earnings & Revenue